article thumbnail

Effects of the COVID-19 pandemic on primary care for diabetes in Canada: Results from a mixed-methods study [Health care services, delivery, and financing]

Annals of Family Medicine

Context: In Canada, most diabetes care is provided within primary care. Qualitative interviews were conducted with Ontario patients aged > 50 with diagnosis of (or receiving treatment for) type 2 diabetes prior to pandemic onset. Primary care experienced challenges during the COVID-19 pandemic, such as reduced access to care.

article thumbnail

The Future Of Vision And Eye Care

The Medical Futurist

billion people were living with vision loss in 2020, and it is forecasted to reach 1.7 Researchers say that the implant cannot provide any highly detailed vision – but it can help patients detect distinct patterns such as door frames and shapes. Globally 1.1 billion without serious interventions and investments by 2050.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Overtreatment of prostate cancer in the active surveillance era

Common Sense Family Doctor

in 2020, with higher percentages of patients with more favorable pathology or lower PSA levels choosing one of these strategies. A 2019 AFP editorial provided more guidance for estimating and having conversations about life expectancy with older patients. ** This post first appeared on the AFP Community Blog. and 6.1%, respectively).

article thumbnail

Insights into the design, development and implementation of a novel digital health tool for skilled birth attendants to support quality maternity care in Kenya

BMJ

doi: 10.1136/fmch-2020-000845 The appetite for and ability to collect accurate digital patient-level data in low-resource settings has fueled numerous massive global health initiatives. As impressive as these large numbers may be, the question that is less often asked is “How much of that big data is actually helping us do better?”

article thumbnail

COVID At-Home Antigen Tests: If at First You Don’t Succeed Try, Try and Try Again

FDA Law Blog

These practical benefits are in marked contrast to molecular COVID-19 tests that are used for definitive diagnosis and are generally expected to detect the SARS-CoV-2 virus at least 95% of the time when someone is infected. After two negative tests, you should consider a molecular test, or call your healthcare provider.

article thumbnail

Knock, Knock. Who’s There? Breakthrough Device. Breakthrough Device Who? Breakthrough Device That Can’t Get to Market

FDA Law Blog

In particular, CDRH touts its Breakthrough Devices Program, which it advertises as a “program for certain medical devices and device-led combination products that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions.

Clinic 64
article thumbnail

A portrait of primary care use in community dwelling persons with dementia in Quebec between 2018 and 2020 [Health care disparities]

Annals of Family Medicine

Objective To provide a comprehensive overview of primary care use among community-dwelling persons with dementia in Quebec from 2018 to 2020. Population Studied Community-dwelling persons aged 65 and older with a prevalent diagnosis of dementia on March 1st of 2018, 2019, and 2020. 60.8%, 60.2%, and 58.8%